Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2819670 Title: COMPOSITION PHARMCEUTIQUE ET LEURS ADMINISTRATIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
137086252
WO application number:
US2013028097
Type:
European patent granted for BE
Status:
Open
Publication number:
2819670
WO publication number:
WO2013130669
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
27/02/2013
Grant date:
20/05/2026
EP publication date:
07/01/2015
WO publication date:
06/09/2013
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
20/05/2026
EP B1 publication date:
20/05/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
27/02/2033

Applicant

Name:
Vertex Pharmaceuticals Incorporated
Legal Form:
From:
20/05/2026
Address:
50 Northern Avenue, Boston, MA 02210, United States (US)
To:

Inventor

1

Name:
DOKOU, Eleni
Legal Form:
Address:
Cambridge, MA 02140, United States (US)

2

Name:
JAMZAD, Shahla
Legal Form:
Address:
Belmont, MA 02478, United States (US)

3

Name:
CAESAR, John, P., Jr.
Legal Form:
Address:
Lancaster, MA 01523, United States (US)

4

Name:
FAWAZ, Majed
Legal Form:
Address:
Foxboro, MA 02035, United States (US)

5

Name:
DAS, Laura
Legal Form:
Address:
Charlestown, MA 02129, United States (US)

6

Name:
GU, Chong-Hui
Legal Form:
Address:
Waban, MA 02468, United States (US)

7

Name:
HURTER, Patricia, Nell
Legal Form:
Address:
Harvard, MA 01451, United States (US)

8

Name:
ISRANI, Meghna, Jai
Legal Form:
Address:
Boston, MA 02115, United States (US)

9

Name:
JOHNSTON, Meghan, M.
Legal Form:
Address:
Wakefield, MA 01880, United States (US)

10

Name:
KNEZIC, Dragutin
Legal Form:
Address:
Watertown, MA 02472, United States (US)

11

Name:
KUZMISSION, Andrew, G.
Legal Form:
Address:
Shrewsbury, MA 01545, United States (US)

12

Name:
WANG, Hongren
Legal Form:
Address:
Lexington, MA 02420, United States (US)

Priority

1

Priority patent number:
201261710352 P
Priority date:
05/10/2012
Priority country:
United States (US)

2

Priority patent number:
201261603882 P
Priority date:
27/02/2012
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/47; A61K 9/16; A61K 47/02; A61K 47/26; A61K 47/32; A61K 47/38;

Publication

European Patent Bulletin

Issue number:
202621
Publication date:
20/05/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/03/2027
Annual fee number:
15
Annual fee amount:
360 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type